Johnson & Johnson (JNJ) Cash & Equivalents (2009 - 2026)
Johnson & Johnson's Cash & Equivalents came in at $16.91 billion for Q3 2026, down 7.2% from $18.23 billion a year earlier and down 17.2% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Johnson & Johnson's Cash & Equivalents was $19.71 billion, down 18.2% from FY2024.
- Cash & Equivalents carries a four-year compound annual growth rate of 9.0% (FY2021 to FY2025).
- Going back by year, Cash & Equivalents was $24.11 billion in FY2024 (+10.3%), $21.86 billion in FY2023 (+69.6%), $12.89 billion in FY2022 and $13.99 billion in FY2021.
- The Q3 2026 figure represents the lowest quarterly Cash & Equivalents since Q4 2022.
- Year-over-year, Cash & Equivalents increased in three of the last eight quarters, with an average decline of 4.0%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2023 (growth of 69.6%), and the weakest in Q1 2026 (a decline of 43.6%).
- Business Quant data shows JNJ's Cash & Equivalents at $20.42 billion (Q2 2026), $21.69 billion (Q1 2026) and $19.71 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Vertex Pharmaceuticals | 132.74 Bn | 104.74 Bn | 2.84 Bn | 6.14 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 16.91 Bn |
| Jun 28, 2026 | 20.42 Bn |
| Mar 29, 2026 | 21.69 Bn |
| Dec 28, 2025 | 19.71 Bn |
| Sep 28, 2025 | 18.23 Bn |
| Jun 29, 2025 | 18.58 Bn |
| Mar 30, 2025 | 38.47 Bn |
| Dec 29, 2024 | 24.11 Bn |
| Sep 29, 2024 | 19.98 Bn |
| Jun 30, 2024 | 24.88 Bn |
| Mar 31, 2024 | 25.47 Bn |
| Dec 31, 2023 | 21.86 Bn |
| Oct 1, 2023 | 19.73 Bn |
| Jul 2, 2023 | 21.18 Bn |
| Apr 2, 2023 | 19.17 Bn |
| Jan 1, 2023 | 12.89 Bn |
| Oct 2, 2022 | 11.36 Bn |
| Jul 3, 2022 | 10.98 Bn |
| Apr 3, 2022 | 10.46 Bn |
| Jan 2, 2022 | 14.49 Bn |
API Access
Johnson & Johnson Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();